2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O18] Oral Session 18　Gastrointestinal Cancer 3（Lower GI Tract-Colorectal Cancer 2）
【E】

Sat. Feb 19, 2022 10:10 AM - 11:40 AM Room 12 (Prince Hall 2, B2F, The Prince Kyoto Takaragaike)

Chair：Eiji Oki（Department of Surgery and Science, Kyushu University），Kei Muro（Department of Clinical Oncology, Aichi Cancer Center Hospital）
Discussant：Hiroya Taniguchi（Department of Clinical Oncology, Aichi Cancer Center Hospital）

[O18-6] Safety of encorafenib, binimetinib, plus cetuximab for Japanese patients with BRAF V600E metastatic colorectal cancer

○Toshifumi Yamaguchi1, Kotani Daisuke2, Takashima Atsuo3, Kato Takeshi4, Masuishi Toshiki5, Komatsu Yoshito6, Shiozawa Manabu7, Esaki Taito8, Izawa Naoki9, Takeuchi Shinji10, Bando Hideaki2, Iwasa Satoru3, Hasegawa Hiroko4, Satoh Taroh1, Taniguchi Hiroya5, Yoshino Takayuki2 (1.Osaka University Hospital, 2.National Cancer Center Hospital East, 3.National Cancer Center Hospital, 4.National Hospital Organization Osaka National Hospital, 5.Aichi Cancer Center Hospital, 6.Hokkaido University Hospital, 7.Kanagawa Cancer Center, 8.National Hospital Organization Kyushu Cancer Center, 9.St. Marianna University School of Medicine Hospital, 10.Kanazawa University Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password